Skip to content

PSYCHEMEDICS CORPORATION: 10-K filed 2013-03-08

What PSYCHEMEDICS CORPORATION reported in its annual report filed 2013-03-08 (fiscal FY 2012): 39 published measures, 145 facts as tagged in accession 0001144204-13-013811.

This filing

Form
10-K (annual report)
Filed
2013-03-08
Fiscal period
fiscal FY 2012
Accession
0001144204-13-013811 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PSYCHEMEDICS CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-12-3114,120,618USD
At 2011-12-3113,800,852USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-12-312,897,949USD
At 2011-12-312,766,223USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-12-3111,222,669USD
At 2011-12-3111,034,629USD
At 2010-12-319,747,513USD
At 2009-12-319,294,384USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-12-313,065,785USD
At 2011-12-315,564,233USD
At 2010-12-313,720,488USD
At 2009-12-314,840,367USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-10-01 to 2012-12-31273,000USD92
2012-01-01 to 2012-12-312,979,629USD366
2012-07-01 to 2012-09-30879,000USD92
2012-04-01 to 2012-06-301,001,000USD91
2012-01-01 to 2012-03-31827,000USD91
2011-10-01 to 2011-12-31438,000USD92
2011-01-01 to 2011-12-313,489,283USD365
2011-07-01 to 2011-09-301,099,000USD92
2011-04-01 to 2011-06-301,093,000USD91
2011-01-01 to 2011-03-31858,000USD90
2010-01-01 to 2010-12-312,613,720USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-12-313,086,731USD366
2011-01-01 to 2011-12-313,935,201USD365
2010-01-01 to 2010-12-313,295,397USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-12-312,214,048USD366
2011-01-01 to 2011-12-311,358,790USD365
2010-01-01 to 2010-12-31817,960USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-3,249,756USD366
2011-01-01 to 2011-12-31-2,620,244USD365
2010-01-01 to 2010-12-31-2,555,563USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-2,335,423USD366
2011-01-01 to 2011-12-31528,788USD365
2010-01-01 to 2010-12-31-1,859,713USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-12-31-7,186,009USD
At 2011-12-31-7,009,046USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2012-01-01 to 2012-12-315,260,320shares366
2011-01-01 to 2011-12-315,229,646shares365
2010-01-01 to 2010-12-315,207,244shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2012-01-01 to 2012-12-315,272,542shares366
2011-01-01 to 2011-12-315,235,940shares365
2010-01-01 to 2010-12-315,226,454shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2012-10-01 to 2012-12-310.05USD/shares92
2012-01-01 to 2012-12-310.57USD/shares366
2012-07-01 to 2012-09-300.17USD/shares92
2012-04-01 to 2012-06-300.19USD/shares91
2012-01-01 to 2012-03-310.16USD/shares91
2011-10-01 to 2011-12-310.08USD/shares92
2011-01-01 to 2011-12-310.67USD/shares365
2011-07-01 to 2011-09-300.21USD/shares92
2011-04-01 to 2011-06-300.21USD/shares91
2011-01-01 to 2011-03-310.16USD/shares90
2010-01-01 to 2010-12-310.5USD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2012-10-01 to 2012-12-310.05USD/shares92
2012-01-01 to 2012-12-310.57USD/shares366
2012-07-01 to 2012-09-300.17USD/shares92
2012-04-01 to 2012-06-300.19USD/shares91
2012-01-01 to 2012-03-310.16USD/shares91
2011-10-01 to 2011-12-310.08USD/shares92
2011-01-01 to 2011-12-310.67USD/shares365
2011-07-01 to 2011-09-300.21USD/shares92
2011-04-01 to 2011-06-300.21USD/shares91
2011-01-01 to 2011-03-310.16USD/shares90
2010-01-01 to 2010-12-310.5USD/shares365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2012-01-01 to 2012-12-311,957,948USD366
2011-01-01 to 2011-12-312,316,513USD365
2010-01-01 to 2010-12-311,823,834USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-12-314,201,409USD
At 2011-12-312,063,377USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-12-31458,167USD366
2011-01-01 to 2011-12-31418,077USD365
2010-01-01 to 2010-12-31394,972USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-10-01 to 2012-12-31464,000USD92
2012-01-01 to 2012-12-314,935,688USD366
2012-07-01 to 2012-09-301,431,000USD92
2012-04-01 to 2012-06-301,664,000USD91
2012-01-01 to 2012-03-311,377,000USD91
2011-10-01 to 2011-12-31746,000USD92
2011-01-01 to 2011-12-315,800,450USD365
2011-07-01 to 2011-09-301,808,000USD92
2011-04-01 to 2011-06-301,758,000USD91
2011-01-01 to 2011-03-311,490,000USD90
2010-01-01 to 2010-12-314,414,463USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-12-319,573,916USD
At 2011-12-3111,500,301USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-12-312,083,330USD
At 2011-12-312,283,700USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-12-31669,789USD
At 2011-12-31961,844USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-12-314,620,768USD
At 2011-12-314,490,976USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2012-01-01 to 2012-12-310USD366
2011-01-01 to 2011-12-3122,391USD365
2010-01-01 to 2010-12-316,034USD365

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-01-01 to 2012-12-319,315,960USD366
2011-01-01 to 2011-12-318,672,173USD365
2010-01-01 to 2010-12-317,627,170USD365

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-10-01 to 2012-12-312,766,000USD92
2012-01-01 to 2012-12-3114,251,648USD366
2012-07-01 to 2012-09-303,718,000USD92
2012-04-01 to 2012-06-304,103,000USD91
2012-01-01 to 2012-03-313,665,000USD91
2011-10-01 to 2011-12-313,173,000USD92
2011-01-01 to 2011-12-3114,472,623USD365
2011-07-01 to 2011-09-303,944,000USD92
2011-04-01 to 2011-06-303,739,000USD91
2011-01-01 to 2011-03-313,617,000USD90
2010-01-01 to 2010-12-3112,041,633USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-01-01 to 2012-12-31825,518USD366
2011-01-01 to 2011-12-31607,408USD365
2010-01-01 to 2010-12-31481,433USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-12-315,272,428shares
At 2011-12-315,235,422shares

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-12-318,597,014USD
At 2011-12-3113,089,655USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-12-314,395,605USD
At 2011-12-3111,026,278USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-12-31345,293USD
At 2011-12-31237,174USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2012-12-311,413,541USD
At 2011-12-311,321,856USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-12-31823,274USD
At 2011-12-31565,508USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2012-01-01 to 2012-12-314,937,577USD366
2011-01-01 to 2011-12-315,805,796USD365
2010-01-01 to 2010-12-314,437,554USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-12-313,946,844USD366
2011-01-01 to 2011-12-313,948,706USD365
2010-01-01 to 2010-12-314,195,998USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-01-01 to 2012-12-31586,968USD366
2011-01-01 to 2011-12-31370,020USD365
2010-01-01 to 2010-12-31284,911USD365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2012-01-01 to 2012-12-311,520,228USD366
2011-01-01 to 2011-12-311,909,660USD365
2010-01-01 to 2010-12-311,605,680USD365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2012-01-01 to 2012-12-31437,720USD366
2011-01-01 to 2011-12-31406,853USD365
2010-01-01 to 2010-12-31218,154USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-31129,792USD366
2011-01-01 to 2011-12-31585,155USD365
2010-01-01 to 2010-12-31889,737USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-292,055USD366
2011-01-01 to 2011-12-31262,011USD365
2010-01-01 to 2010-12-31519,049USD365

Inspect the source

Entity
PSYCHEMEDICS CORPORATION / CIK 0000806517
Captured
2026-09-21T17:17:03.097Z
SEC response SHA-256
86f20b52a099e76620fe6881a053ed61515c47925a0b1b6a4ed64f7b833f6a17

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000806517.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))